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Objective: This study explored the prevalence of panic disorder and other psychiatric disorders 
in young Han Chinese males with mitral valve prolapse (MVP). With the factors of age, sex, 
and ethnicity controlled, the speciﬁ  c role of MVP in panic disorder was analyzed.
Methods: Subjects with chest pain aged between 18 and 25 years were assessed with the 
echocardiograph for MVP and the Chinese version of the Mini-International Neuropsychiatric 
Interview for panic disorder (n = 39).
Results: Of the 39 participants, 35.9% met the diagnosis of anxiety disorder, 46.2% met at 
least one criterion of anxiety disorder, and 23.1% met the diagnostic criteria of major depressive 
disorder. There was no statistically signiﬁ  cant difference in the prevalence of panic disorder 
between one of the (8.3%) MVP patients, and two (7.4%) control participants.
Conclusions: There is a high prevalence of psychiatric disorder, including anxiety disorder 
and major depressive disorder, in those who report pain symptoms, so that diagnosis and 
treatment of these patients is of great importance. In addition, individuals with MVP did not 
have an increased risk for panic disorder. Whether MVP may be a modiﬁ  er or mediating factor 
for panic disorder needs to be further assessed in a larger scale study.
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Introduction
There is a high cormorbidity between the psychiatric symptoms of depression and 
anxiety, and somatoform disorders in primary care (Mergl et al 2007). Patients in 
primary care who report pain symptoms are often found to have depression or anxiety, 
but these psychiatric disorders are underdiagnosed (Means-Christensen et al 2008). 
One study found that only half of the depressed patients were recognized, and only 
15% to 26% were diagnosed (Lecrubier 2007). Another study found that 19.5% of 
patients in primary care had anxiety disorder, but nearly half of these patients remained 
untreated (Kroenke et al 2007; Weisberg et al 2007).
The patient’s distress increases if he or she cannot be correctly diagnosed, and thus 
receive adequate treatment or if, after correct diagnosis appropriate treatment is not 
available in a primary care setting. Such events may mean higher utilization of medical 
care services (Demertzis and Craske 2006). However, effective psychotherapeutic 
intervention for primary care patients has been developed (Lang et al 2006). Thus 
understanding of these medically unexplained somatic symptoms and psychiatric 
comorbidities is important to help physicians provide more suitable diagnoses and 
treatment for these patients (Schur et al 2007).
Among these psychiatric disorders, panic disorder has been estimated to have 
4% to 6% prevalence in the general population (Messias et al 2007). The diagnosis 
of panic disorder, as ﬁ  rst listed in the DSM-III, biologically differentiated it from 
anxiety neurosis (Lieb 2005). Predisposing factors for panic disorder include a genetic Journal of Multidisciplinary Healthcare 2008:1 90
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contribution (Freitag et al 2006; Fyer et al 2006; Rothe et al 
2006), which has been found to have ethnic heterogeneity 
(Domschke et al 2007), and gender speciﬁ  city (Unschuld 
et al 2008). Compared with males, females have almost twice 
the risk for developing panic disorder (Andrade et al 1996). 
Panic disorder has been found to be highly comorbid with 
agoraphobia (Bienvenu et al 2006) and migraine (Swartz 
et al 2000), and patients who have co-morbid disorders have 
a greater severity of panic disorder (Andrade et al 1996). 
Precipitating factors which increase the risk of panic disorder 
include a family history of panic disorder (Nardi et al 2006), 
a personal history of anxiety, depression (Gregory et al 2007), 
and cardiac symptoms (Keyl and Eaton 1990). Since the 
variability in the predisposing and precipitating factors and 
comorbility in panic disorder is high, the nosology of panic 
disorder is still not perfect (Eaton et al 1995).
Research has found that more than 30% of patients 
with panic disorders have been diagnosed with mitral valve 
prolapse (MVP) (Liberthson et al 1986). A possible rela-
tionship is believed to exist between these two disorders, 
although research has shown inconsistent ﬁ  ndings for such 
an association (Margraf et al 1988). According to Margraf 
and colleagues (1988), the reason for inconsistent results 
may be due to widely differing diagnostic criteria for MVP, 
lack of reliability of these criteria, and sampling bias in 
both case and controls. Some symptoms of MVP, such as 
chest oppression and palpitation, can evoke a panic attack. 
Hence, it is believed that panic disorder could be caused 
by MVP, or conversely, panic disorder may result in MVP 
(Pariser et al 1978; Gorman et al 1981; Filho et al 2008). 
Because the nosology of panic disorder is still not clear, it 
is possible that the association between panic disorder and 
MVP is coincidental.
Whether or not MVP patients are at higher risk for panic 
disorder and other psychiatric illnesses, and what percentage 
of MVP patients have experienced panic attack, are still 
uncertain (Tamam et al 2000). Therefore the aim of our study 
was to investigate the prevalence of panic disorder and other 
psychiatric disorders in young Han Chinese males with MVP. 
We controlled for age, sex, and ethnicity, and focused on the 
speciﬁ  c role MVP played in panic disorders.
Methods
Participants
Approval was ﬁ  rst obtained from the institutional review 
board at a teaching hospital in southern Taiwan. Written 
informed consent was collected from all participants after a 
detailed explanation of the purpose of the study.
The participants were 18–25-year-old Taiwanese who 
came to the cardiac outpatient department with chest pain. 
Patients with congenital heart disease, cardiomyopathy, 
rheumatic heart disease, endocarditis, valve regurgitation, 
and hypertension were excluded. The echocardiograph was 
used by a senior cardiologist to diagnose MVP, and a total 
of 39 participants were recruited. All participants lived in a 
teaching hospital for at least one month to verify the diag-
nosis, and were interviewed by a senior psychiatrist, using 
the Mini-International Neuropsychiatric Interview (MINI) 
(Sheehan et al 1998).
Materials
This study used the Chinese version of the Mini-International 
Neuropsychiatric Interview (MINI) for the diagnosis of psy-
chiatric disorders. The MINI was developed by Sheehan and 
colleagues (1998), and the Chinese version was translated 
by Lee and colleagues (unpublished data); this version has 
demonstrated good reliability and validity for diagnosing 
panic disorder.
Statistical analysis
Data were analyzed using SPSS 15.0 for Windows (SPSS 
Inc., Chicago, IL). All variables were analyzed using descrip-
tive and chi-square analysis.
Results
Demographic distribution 
and psychiatric prevalence
Thirty-nine males between the ages of 18 and 25 participated 
in the study. Using echocardiographs, 12 (30.8%) were 
diagnosed with MVP. The control group consisted of 
27 (69.2%) participants who had no abnormalities in the echo-
cardiograph, but who complained of chest discomfort. The 
medical history and current symptoms of all participants met 
the diagnosis of at least one psychiatric disorder; 14 (35.9%) 
met the diagnosis of anxiety disorder, and 18 (46.2%) met 
at least one criterion for anxiety disorder. Nine (23.1%) 
participants met the diagnostic criteria of major depressive 
disorder or other mood disorders.
The association between MVP 
and panic disorder
One (8.3%) MVP patient and two (7.4%) individuals in the 
control group met the diagnostic criteria of panic disorder 
at the time of the study. One (8.3%) MVP patient and no 
individuals in the control group had a previous history of Journal of Multidisciplinary Healthcare 2008:1 91
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panic disorder. No statistically signiﬁ  cant difference was 
found in the prevalence of panic disorder between the two 
groups.
The association between MVP 
and other psychiatric disorders
Using the MINI survey as the diagnostic tool for all 
psychiatric disorders, no statistically signiﬁ  cant difference 
was found in the prevalence of psychiatric disorders between 
the MVP group and the control group.
Discussion
The results of our study showed that, among cardiac 
outpatient department individuals who reported chest 
discomfort, 35.9% of the patients met the diagnosis of anxiety 
disorder, 46.2% met at least one criterion of anxiety disorder, 
and 23.1% met the diagnostic criteria of major depressive 
disorder. This prevalence is higher than the 19.5% prevalence 
of anxiety disorder found by Kroenke and colleagues (2007) 
in a primary care setting. Some possible reasons, including 
ethnic and cultural differences, may contribute to the preva-
lence in the Chinese population. In general, Chinese tend 
to express somatically when coping with stress (Kleinman 
1977; Parker et al 2001), and men especially tend to suffer 
from more frequent somatic complaints and anxiety (Tang 
and Lau 1996). The complaints could be related to social-
cultural factors (Gackenbach 1982; Steer et al 1989), and 
to personality factors, which might have caused the higher 
prevalence in the present study.
Another reason might be the small sample, which is a 
limitation of our study. A possible type II error is our ﬁ  nding 
of a higher prevalence of psychiatric disorders in Chinese 
populations. Increasing the sample size of the subjects could 
help to conﬁ  rm the prevalence of psychiatric disorders among 
MVP patients in further studies.
No statistically signiﬁ  cant differences in the prevalence 
of panic disorder and other psychiatric disorders were found 
between the MVP and control groups, thereby demonstrating 
that MVP is not a risk factor for panic disorder. Patients with 
panic disorder are more likely to have cardiac abnormali-
ties compared with controls (Venkatesh et al 1980), and the 
prevalence of MVP in panic disorder is high (Liberthson 
et al 1986). A previous study even proposed that MVP may 
play a role in the etiology of anxiety disorder (Hamada et al 
1990). However, our study did not ﬁ  nd that patients with 
MVP have a higher risk of panic disorder. Although the 
preliminary results of our study are limited by the sample 
size, all participants sought help at the cardiac outpatient 
department, and had symptoms of chest discomfort; we 
controlled for ethnic group, gender, and age. The onset 
age of panic disorder was found to peak at between 15 and 
19 years in one study (Von Korff et al 1985). Our participants 
were all between the ages of 18 and 25, and consequently 
the duration of illness for most of our subjects should not 
have been too long, thus reducing the chance for them 
to develop comorbid psychiatric and physical illnesses. 
Whether MVP may be a modiﬁ  er or mediating factor for 
panic disorder needs to be further assessed in a larger scale 
study. In the present study, we also emphasize the need to 
establish adequate treatment for anxiety and mood disor-
ders in primary care settings (Mechanic 2007), especially 
because other studies have indicated the under-diagnosis of 
psychiatric disorders in primary care settings (Kroenke et al 
2007; Means-Christensen et al 2008). Furthermore, even 
those who have been diagnosed may not receive adequate 
treatment (Kroenke et al 2007; Weisberg et al 2007). This 
co-occurrence deserves attention in clinical practice, as well 
as attention to the prevalence of psychiatric disorders among 
patients suffering from MVP.
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